Public health and the preservation of economic competitiveness: the European supplementary protection certificate for medicinal products

被引：0

作者：

Delcourt, Diane ^{[1
]}

机构：

[1] Univ Paul Cezanne, Law, Aix En Provence, France

来源：

JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE | 2009年 / 4卷 / 06期

关键词：

D O I：

10.1093/jiplp/jpp044

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

[No abstract available]

引用

页码：439 / 444

页数：6

共 50 条

[21] IMPACT OF ADVANCED THERAPY MEDICINAL PRODUCTS COST ON PUBLIC HEALTH CARE BUDGETS
Toumi, M.
Kornfeld, A.
Charaf, A.
VALUE IN HEALTH, 2014, 17 (03) : A19 - A19
[22] Regulation of Medicinal Plants for Public Health - European Community Monographs on Herbal Substances
Knoess, Werner
Chinou, Ioanna
PLANTA MEDICA, 2012, 78 (12) : 1311 - 1316
[23] The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
Seitz C.
ERA Forum, 2023, 23 (4) : 543 - 566
[24] “Actavis Group and Actavis”Regulation (EC) No 469/2009 Concerning the Supplementary Protection Certificate for Medicinal Products, Art. 3 – Actavis Group PTC EHF and Actavis UK Ltd v. Sanofi
IIC - International Review of Intellectual Property and Competition Law, 2014, 45 (5) : 587 - 587
[25] “Eli Lilly and Company”Regulation (EC) No 469/2009 Concerning the Supplementary Protection Certificate for Medicinal Products, Art. 3(a) – Eli Lilly and Company Ltd v. Human Genome Sciences Inc.
IIC - International Review of Intellectual Property and Competition Law, 2014, 45 (5) : 588 - 588
[26] Child protection or professional self-preservation by the baby nurses? Public health nurses and child protection in Ireland
Butler, S
SOCIAL SCIENCE & MEDICINE, 1996, 43 (03) : 303 - 314
[27] MEDICAL AND PUBLIC-HEALTH RESEARCH OF THE EUROPEAN ECONOMIC-COMMUNITY
STEIN, H
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1986, 77 : 144 - 149
[28] Does the development of new medicinal products in the European Union address global and regional health concerns?
Ferrán Catalá-López,
Anna García-Altés,
Elena Álvarez-Martín
Ricard Gènova-Maleras
Consuelo Morant-Ginestar
Population Health Metrics, 8
[29] Does the development of new medicinal products in the European Union address global and regional health concerns?
Catala-Lopez, Ferran
Garcia-Altes, Anna
Alvarez-Martin, Elena
Genova-Maleras, Ricard
Morant-Ginestar, Consuelo
POPULATION HEALTH METRICS, 2010, 8
[30] Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries
Gozzo, Lucia
Romano, Giovanni Luca
Romano, Francesca
Brancati, Serena
Longo, Laura
Vitale, Daniela Cristina
Drago, Filippo
FRONTIERS IN PHARMACOLOGY, 2021, 12

← 1 2 3 4 5 →